Sandoz Group AG (SWX:SDZ)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
68.02
-2.32 (-3.30%)
At close: Feb 27, 2026
68.70%
Market Cap 29.30B
Revenue (ttm) 8.85B
Net Income (ttm) 724.76M
Shares Out 430.70M
EPS (ttm) 1.66
PE Ratio 41.04
Forward PE 22.07
Dividend 0.80 (1.14%)
Ex-Dividend Date Apr 13, 2026
Volume 1,330,025
Average Volume 831,524
Open 69.12
Previous Close 70.34
Day's Range 67.58 - 69.70
52-Week Range 26.25 - 72.70
Beta 0.26
RSI 58.86
Earnings Date Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 20,000
Stock Exchange SIX Swiss Exchange
Ticker Symbol SDZ
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.